These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
232 related articles for article (PubMed ID: 7741319)
1. Skin oxygen pressure histograms in patients with peripheral arterial occlusive disease during intraarterial and intravenous prostaglandin E1 infusions of different dosages and their prognostic value. Creutzig A; Arnold A; Caspary L; Thum J; Alexander K Angiology; 1995 May; 46(5):357-67. PubMed ID: 7741319 [TBL] [Abstract][Full Text] [Related]
2. Intra-arterial and intravenous administration of prostaglandin E1 cause different changes to skin microcirculation in patients with peripheral arterial occlusive disease. Thum J; Caspary L; Creutzig A; Alexander K Vasa; 1998 May; 27(2):100-5. PubMed ID: 9612114 [TBL] [Abstract][Full Text] [Related]
3. Skin surface oxygen pressure fields during administration of prostaglandin E1 in patients with arterial occlusive disease. Creutzig A; Caspary L; Alexander K Klin Wochenschr; 1990 Feb; 68(4):207-12. PubMed ID: 2314008 [TBL] [Abstract][Full Text] [Related]
4. [Effect of intra-arterial and intravenous PGE1 infusions on transcutaneous oxygen pressure in patients with critical ischemia of the extremities]. Weiss T; Griesshaber J; Rogatti W; Kistner O; Hsu E; Jansen T; Diehm C Vasa Suppl; 1991; 33():341-2. PubMed ID: 1788749 [TBL] [Abstract][Full Text] [Related]
5. [Double-blind placebo-controlled study of the behavior of tcPO2 during intravenous infusion of prostaglandin E1 in patients with severe arterial occlusive disease]. Creutzig A; Caspary L; Alexander K Vasa Suppl; 1992; 35():36-8. PubMed ID: 1481055 [No Abstract] [Full Text] [Related]
6. Skin surface oxygen pressure in healthy volunteers and patients with arterial occlusive disease. Creutzig A; Caspary L; Alexander K Int J Microcirc Clin Exp; 1991 Aug; 10(3):231-40. PubMed ID: 1955281 [TBL] [Abstract][Full Text] [Related]
7. [Placebo controlled study of the effect of intravenous PGE1 on macro- and microcirculation in patients with stage III/IV arterial occlusive disease]. Scheffler P; de la Hamette D; Leipnitz G Vasa Suppl; 1991; 33():343-4. PubMed ID: 1788750 [TBL] [Abstract][Full Text] [Related]
8. Intravenous infusion of iloprost in arterial occlusive disease: dose-dependent effects on skin microcirculation. Caspary L; Creutzig A; Alexander K Eur J Clin Pharmacol; 1991; 41(2):131-6. PubMed ID: 1720738 [TBL] [Abstract][Full Text] [Related]
9. A comparative analysis of transcutaneous oximetry (tcPO2) during oxygen inhalation and leg dependency in severe peripheral arterial occlusive disease. Scheffler A; Rieger H J Vasc Surg; 1992 Aug; 16(2):218-24. PubMed ID: 1495145 [TBL] [Abstract][Full Text] [Related]
10. Transcutaneous oxygen pressure measured at two different electrode core temperatures in healthy volunteers and patients with arterial occlusive disease. Creutzig A; Dau D; Caspary L; Alexander K Int J Microcirc Clin Exp; 1987; 5(4):373-80. PubMed ID: 3557822 [TBL] [Abstract][Full Text] [Related]
11. Orthostatic vasoconstrictor response in patients with occlusive arterial disease assessed by laser Doppler flux and transcutaneous oximetry. Caspary LA; Creutzig A; Alexander K Angiology; 1996 Feb; 47(2):165-73. PubMed ID: 8595012 [TBL] [Abstract][Full Text] [Related]
12. Transcutaneous PO2 and laser Doppler flowmetry in patients with arterial occlusive disease receiving intraarterial infusions of PGE1 or nucleotide phosphates. Caspary L; Creutzig A; Alexander K Prog Clin Biol Res; 1987; 242():433-8. PubMed ID: 2959965 [No Abstract] [Full Text] [Related]
13. Transcutaneous oxygen pressure as predictive parameter for ulcer healing in endstage vascular patients treated with spinal cord stimulation. Claeys LG; Horsch S Int Angiol; 1996 Dec; 15(4):344-9. PubMed ID: 9127776 [TBL] [Abstract][Full Text] [Related]
14. Effects of intravenous prostaglandin E1 on arterial compliance: a randomized controlled trial. Mlekusch W; Schillinger M; Sabeti S; Al-Awami M; Gschwandtner M; Minar E Vasa; 2004 Aug; 33(3):131-6. PubMed ID: 15461064 [TBL] [Abstract][Full Text] [Related]
15. Therapeutic efficacy of intravenously applied prostaglandin E1. Scheffler P; de la Hamette D; Leipnitz G Vasa Suppl; 1989; 28():19-25. PubMed ID: 2609240 [TBL] [Abstract][Full Text] [Related]
16. Changes of dermal haemoglobin oxygenation and concentration in healthy subjects and in patients with peripheral arterial occlusive disease during and after acute ischemia. Thum J; Caspary L; Creutzig A Vasa; 1997 Aug; 26(3):199-204. PubMed ID: 9286152 [TBL] [Abstract][Full Text] [Related]
17. Effects of intra-arterial prostaglandin E1 in patients with peripheral arterial occlusive disease. Creutzig A; Creutzig H; Alexander K Eur J Clin Invest; 1986 Dec; 16(6):480-5. PubMed ID: 3104047 [TBL] [Abstract][Full Text] [Related]
18. Haemodynamic effects of intra-arterial and intravenous administration of prostaglandin E1 in patients with peripheral arterial disease. Hirai M; Nakayama R Br J Surg; 1986 Jan; 73(1):20-3. PubMed ID: 3947867 [TBL] [Abstract][Full Text] [Related]
19. Transcutaneous oxygen tension and Doppler ankle pressure during upper and lower body exercise in patients with peripheral arterial occlusive disease. Liu Y; Steinacker JM; Stauch M Angiology; 1995 Aug; 46(8):689-98. PubMed ID: 7639415 [TBL] [Abstract][Full Text] [Related]
20. Variability and reproducibility of transcutaneous oxygen tension measurements in the assessment of peripheral vascular disease. Rooke TW; Osmundson PJ Angiology; 1989 Aug; 40(8):695-700. PubMed ID: 2757262 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]